Clinical trialNCT01839396CompletedInterventional

Deep Brain Stimulation (DBS) for the Treatment of Parkinson's Disease

SponsorBoston Scientific CorporationEnrollment313Parkinson's Disease

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the safety and effectiveness of Boston Scientific's Vercise Deep Brain Stimulation (DBS) system in the treatment of patients with with advanced, levodopa-responsive bilateral Parkinson's disease (PD) which is not adequately controlled with medication.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Jerrold Vitek, MD, PhD
University of Minnesota, Neurology Department
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗
Philip Starr, MD, PhD
Universiry of California, San Francisco, Surgical Movement Disorders Clinic
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Muhammad Ali Parkinson Research Center and Movement Disorders Clinic
Phoenix, Arizona, United States
Cedars-Sinai Medical Center
Los Angeles, California, United States
Kaiser Permanente, Sacramento
Sacramento, California, United States
University of California, San Francisco
San Francisco, California, United States
Carepoint, Pc D/b/a Blue Sky Neurology
Englewood, Colorado, United States
University of Florida Shands Hospital
Gainesville, Florida, United States
Mayo Clinic, Jacksonville
Jacksonville, Florida, United States
University of Miami, School of Medicine
Miami, Florida, United States
Emory University
Atlanta, Georgia, United States
Northwestern Memorial Hospital
Chicago, Illinois, United States
Rush University Medical Center
Chicago, Illinois, United States
University of Kansas Hospital
Kansas City, Kansas, United States
University of Minnesota
Minneapolis, Minnesota, United States
Albany Medical Center
Albany, New York, United States
Nyu Medical Center
New York, New York, United States
Wake Forest Health Sciences
Winston-Salem, North Carolina, United States
University of Cincinnati
Cincinnati, Ohio, United States
Cleveland Clinic Foundation
Cleveland, Ohio, United States
Allegheny Health Network
Pittsburgh, Pennsylvania, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Vanderbilt University
Nashville, Tennessee, United States
University of Utah
Salt Lake City, Utah, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 17 May 2013
Primary completion: 27 Dec 2016
Completion: 5 Dec 2022
Last update posted: 13 Jul 2023
Registered enrollment: 313
Registry id: NCT01839396

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.